Question 4. What are the strategies for diagnosis and treatment of disorders of glucose metabolism in cystic fibrosis? Diagnostic and treatment strategies for disorders of glucose metabolism in cystic fibrosis;Question 4. Quelles stratégies diagnostiques et thé rapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose? Stratégies diagnostiques et thérapeutiques des troubles du métabolisme glucidique au cours de la mucoviscidose

Archives de Pediatrie

Volumn 10, Issue SUPPL. 3, 2003, Pages

  Bretones, P ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Cystic fibrosis; Diabetes; Review

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CORTICOSTEROID; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; INSULIN LISPRO; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFANILAMIDE; TOLBUTAMIDE;

CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INSULIN TREATMENT; INSULINEMIA; PREVALENCE; ADOLESCENT; ADULT; CHILD; DIFFERENTIAL DIAGNOSIS; INFANT; NEWBORN; PRESCHOOL CHILD; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFANT, NEWBORN; RISK FACTORS;

EID: 0642318352     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (39)

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-97.
2. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. WHO Techn Rep Ser 1985; 727: 1-113.
3. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995; 311: 655-9.
4. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999; 54: 40-3.
5. Cotellessa M, Minicucci L, Lorini R. When should hyperglycemia be treated in cystic fibrosis? J Pediatr 2000; 136: 706-7.
6. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2001; 2: 253-9.
7. Yung B, Kemp M, Hooper J, Hodson M. Random blood glucose alone in the diagnosis of cystic fibrosis related diabetes. Lancet 1997; 349: 619.
8. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-7.
9. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73.
10. Rosenecker J, Eichler I, Kühn L, Harms HK, von der Hardt H, Group MCFS. Genetic determination of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995; 127: 441-3.
11. Moran A, Doberty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998; 133: 10-17.
12. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-50.
13. Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfalt R, Lindblad A, et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 2002; 33: 483-91.
14. Garagorri JM, Rodriguez G, Ros L, Sanchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab 2001; 14: 53-60.
15. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, Di Benedetto A, et al. Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Paediatr 1999; 88: 389-93.
16. Peraldo M, Fasulo A, Chiappini E, Milio C, Marianelli L. Evaluation of glucose tolerance and insulin secretion in cystic fibrosis patients. Horm Res 1998; 49: 65-71.
17. Koch C, Cuppens H, Rainisio M, Madessani U, Harms H, Hodson M, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31: 1-12.
18. Wilson DC, Kalnins D, Stewart C, Hamilton N, Hanna AK, Durie PR, et al. Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus. Clin Nutr 2000; 19: 87-93.
19. Hardin DS, LeBlanc A, Lukenbough S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997; 130: 948-56.
20. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Dracoulacos D, Karamouzis M, Demitriadou A. Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis. J Pediatr Endocrinol Metab 2000; 13: 319-24.
21. Jensen P, Johansen HK, Carmi P, Hoiby N, Cohen IR. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J Autoimmun 2001; 17: 165-72.
22. Carrington M, Krueger LJ, Holsclaw DS Jr, Iannuzzi MC, Dean M, Mann D. Cystic fibrosis-related diabetes is associated with HLA DQB1 alleles encoding Asp-57-molecules. J Clin Immunol 1994; 14: 353-8.
23. Lanng S, Thorsteinsson B, Pociot F, Marshall MO, Madsen HO, Schwartz M, et al. Diabetes mellitus in cystic fibrosis: genetic and immunologic markers. Acta Paediatr 1993; 82: 150-4.
24. Robert JJ, Grasset E, de Montalembert M, Chevenne D, Deschamps I, Boitard C, et al. Recherche de facteurs d'intolérance au glucose dans la mucoviscidose. Arch Fr Pediatr 1992; 49: 17-22.
25. Jankelson D, Robinson M, Parsons S, Torzillo P, Peat B, Bye P. Cystic fibrosis and pregnancy. Aust N Z J Obstet Gynaecol 1998; 38: 180-4.
26. Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE. Pregnancy in Cystic fibrosis. Fetal and maternal outcome. Chest 2000; 118: 85-91.
27. Odegaard I, Stray-Pedersen B, Hallberg K, Haanaes OC, Storrosten OT, Johannesson M. Maternal and fetal morbidity in pregnancies of Norwegian an Swedish women with cystic fibrosis. Acta Obstet Gynecol Scand 2002; 81: 698-705.
28. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-7.
29. Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 1998; 92: 871-2.
30. Yung B, Hodson ME. Diabetes in cystic fibrosis. J R Soc Med 1999; 92 Suppl. 37: 35-40.
31. Lanng S, Thorsteinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 949-53.
32. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-9.
33. Culler FL, McKean LP, Buchanan CN, Caplan DB, Meacham LR. Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr 1994; 18: 375-8.
34. Hinds A, Sheehan AG, Parsons HG. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Metabolism 1995; 44: 13-8.
35. Moran A, Phillips J, Milla C. Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes. Diabetes Care 2001; 24: 1706-10.
36. Rosenecker J, Eichler I, Barmeier H, von der Hardt H. Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001; 32: 351-5.
37. Kentrup H, Bongers H, Spengler M, Kusenbach G, Skopnik H. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance. Eur J Pediatr 1999; 158: 455-9.
38. Cotellessa M, Minicucci L, Diana MC, Prigione F, Di Febbraro L, Gagliardini R, et al. Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study). J Pediatr Endocrinol Metab 2000; 13: 1087-93.
39. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162 (3Pt 1): 891-5.